Mersana Therapeutics buy Guggenheim
Start price
16.05.25
/
50%
€0.31
Target price
16.05.26
€4.46
Performance (%)
-14.13%
Price
25.07.25
€0.26
Summary
This prediction is currently active. The price of Mersana Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.13%. This prediction currently runs until 16.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mersana Therapeutics | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Guggenheim for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $5.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat